Puma Biotechnology

(NASDAQ) PBYI

Current Price$7.05

Market Cap$360.37M

Since IPO (2012)-48%

5 Year-34%

1 Year+118%

1 Month-5%

Puma Biotechnology Financials at a Glance

Market Cap

$360.37M

Revenue (TTM)

$227.18M

Net Income (TTM)

$24.38M

EPS (TTM)

$0.48

P/E Ratio

14.83

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$7.05

Volume

4,738

Open

$7.28

Price

$7.05

Volume

4,738

Open

$7.28

Previous Close

$7.05

Daily Range

$6.99 - $7.28

52-Week Range

$3.03 - $7.90

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$7.05

Volume

4,738

Open

$7.28

Previous Close

$7.05

Daily Range

$6.99 - $7.28

52-Week Range

$3.03 - $7.90

PBYI News

So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature

Maxx ChatskoApr 1, 2020

3 High-Risk, High-Reward Stocks That Have Massive Upside Potential

Mark PrvulovicFeb 29, 2020

Will Puma Biotechnology Break Out of Its Rut in 2020?

Maxx ChatskoFeb 28, 2020

Page 1

PBYI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Puma Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

179

CEO

Alan H. Auerbach

Website

www.pumabiotechnology.com

Headquarters

Los Angeles, CA 90024, US

PBYI Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

13%

Net Income Margin

11%

Return on Equity

22%

Return on Capital

22%

Return on Assets

13%

Earnings Yield

6.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$360.37M

Shares Outstanding

50.90M

Volume

4.74K

Avg. Volume

341.30K

Financials (TTM)

Gross Profit

$170.21M

Operating Income

$37.30M

EBITDA

$53.34M

Operating Cash Flow

$41.80M

Capital Expenditure

$71.00K

Free Cash Flow

$41.73M

Cash & ST Invst.

$97.53M

Total Debt

$28.55M

Puma Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$44.81M

-2.6%

Gross Profit

$34.39M

-3.0%

Gross Margin

76.74%

N/A

Market Cap

$360.37M

N/A

Market Cap/Employee

$2.10M

N/A

Employees

172

N/A

Net Income

$3.75M

-226.2%

EBITDA

$1.33M

-116.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$85.65M

+172.3%

Accounts Receivable

$26.33M

+4.6%

Inventory

$0.00

-100.0%

Long Term Debt

$4.55M

-57.3%

Short Term Debt

$11.41M

-77.7%

Return on Assets

12.65%

N/A

Return on Invested Capital

22.18%

N/A

Free Cash Flow

$15.42M

+334.1%

Operating Cash Flow

$15.42M

+326.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$4.42+4.25%

ABEOAbeona Therapeutics Inc.

ABEOAbeona Therapeutics Inc.$5.44-1.45%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$6.56+3.96%

ELDNEledon Pharmaceuticals, Inc.

ELDNEledon Pharmaceuticals, Inc.$3.89+0.00%

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.00+2.04%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$7.09+1.29%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.80+3.26%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About PBYI

What is the current price of Puma Biotechnology?

Puma Biotechnology is trading at $7.05 per share.

What is the 52-week range for Puma Biotechnology?

Over the past 52 weeks, Puma Biotechnology has traded between $3.03 and $7.90.

How much debt does Puma Biotechnology have?

As of the most recent reporting period, Puma Biotechnology reported total debt of $15.95M.

How much cash does Puma Biotechnology have on hand?

Puma Biotechnology reported $38.28M in cash and cash equivalents in its most recent financial results.

What is Puma Biotechnology’s dividend yield?

Puma Biotechnology does not currently have a dividend yield.

Puma Biotechnology

Puma Biotechnology Financials at a Glance

PBYI News

Puma (PBYI) Q2 Revenue Rises 11%

Why Shares of Puma Biotechnology Rose This Week

Why Puma Biotechnology's Shares Jumped 20% on Monday

Why Puma Biotechnology Shares Dropped 17.7% This Week

Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today

So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature

3 High-Risk, High-Reward Stocks That Have Massive Upside Potential

Will Puma Biotechnology Break Out of Its Rut in 2020?

PBYI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Puma Biotechnology

PBYI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Puma Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PBYI

What is the current price of Puma Biotechnology?

What is the 52-week range for Puma Biotechnology?

How much debt does Puma Biotechnology have?

How much cash does Puma Biotechnology have on hand?

What is Puma Biotechnology’s dividend yield?

Premium Investing Services